Laboratory Ebitda from 2010 to 2024

LH Stock  USD 239.67  0.50  0.21%   
Laboratory's EBITDA is increasing with slightly volatile movements from year to year. EBITDA is predicted to flatten to about 1.1 B. For the period between 2010 and 2024, Laboratory, EBITDA quarterly trend regression had mean deviation of  683,504,563 and range of 4 B. View All Fundamentals
 
EBITDA  
First Reported
1988-03-31
Previous Quarter
463.3 M
Current Value
422.5 M
Quarterly Volatility
261.7 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.0122 or PTB Ratio of 3.28. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Ebitda Growth Pattern

Below is the plot of the Ebitda of Laboratory of over the last few years. It is Laboratory's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Laboratory Ebitda Regression Statistics

Arithmetic Mean1,754,945,111
Geometric Mean1,517,943,822
Coefficient Of Variation55.09
Mean Deviation683,504,563
Median1,576,800,000
Standard Deviation966,728,370
Sample Variance934563.7T
Range4B
R-Value0.51
Mean Square Error749190.7T
R-Squared0.26
Significance0.05
Slope109,290,131
Total Sum of Squares13083892.4T

Laboratory Ebitda History

20241.1 B
20231.3 B
2022B
20214.3 B
20203.3 B
2019B
20182.1 B

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Ebitda, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBITDA1.3 B1.1 B

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
5.26
Revenue Per Share
151.028
Quarterly Revenue Growth
0.074
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.